Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Vaccines

Free Subscription 10.08.2026 2 Ann Intern Med 2 BMJ 2 Clin Infect Dis 1 Infect Immun 2 J Infect 1 J Infect Dis 1 J Pediatr 1 PLoS Comput Biol 2 PLoS One 2 Science 15 Vaccine 1 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Intern Med

1. GOLDMAN JM, Mitchell KM, Hopkins RH Jr
   ACP Supports Updated Adult Vaccination Schedules From AAFP and ACOG.
   Ann Intern Med. 2026 Aug 4. doi: 10.7326/ANNALS-26-03113.
   PubMed        
   
   
2. CHEN V, Glatt AE
   In older adults, mRNA-1010 vs. a licensed standard-dose influenza vaccine reduced influenza A- or B-related ILI at a median 181 d.
   Ann Intern Med. 2026 Aug 4. doi: 10.7326/ANNALS-26-02527.
   PubMed         Abstract available
   
   

   
   BMJ

3. WISE J
   "Fridge-free" vaccine for tetanus-diphtheria shows promise in first human trial.
   BMJ. 2026;394:e100517.
   PubMed        
   
   
4. LANG K
   Ebola: how soon could a Bundibugyo vaccine be ready?
   BMJ. 2026;394:e100450.
   PubMed        
   
   

   
   Clin Infect Dis

5. MUNBLIT D, Buonsenso D, Olliaro PL, Semple MG, et al
   Vaccines, Bias, and the Perils of Non-peer-reviewed Studies: Fueling Misinformation and Vaccine Hesitancy.
   Clin Infect Dis. 2026 Aug 5:ciag403. doi: 10.1093.
   PubMed         Abstract available
   
   
6. PARDO-SECO J, Rodriguez-Tenreiro-Sanchez C, Gine-Vazquez I, Mallah N, et al
   A Bayesian Re-Analysis of the GALFLU Trial of high dose versus standard dose influenza vaccine against hospitalisation outcomes.
   Clin Infect Dis. 2026 Aug 3:ciag466. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Infect Immun

7. HOWLADER DR, Das S, Biswas S, Dietz ZK, et al
   A multivalent subunit vaccine augments pre-existing immunity to protect against T3SS-positive Pseudomonas aeruginosa but reveals immunological interference against ExlA-positive strains.
   Infect Immun. 2026 Aug 4:e0017526. doi: 10.1128/iai.00175.
   PubMed         Abstract available
   
   

   
   J Infect

8. LI X, Mercade-Besora N, Lam AS, Barboza C, et al
   Effectiveness and waning of the fourth dose mRNA COVID-19 vaccines for the prevention of SARS-CoV2 infection related hospitalisations and deaths.
   J Infect. 2026 Aug 5:106825. doi: 10.1016/j.jinf.2026.106825.
   PubMed         Abstract available
   
   
9. ZHANG Y, Shrestha S, Feaheny F, Pant D, et al
   Impact of dosing interval on immunogenicity following a heterologous typhoid conjugate vaccine booster in Nepalese children: an observational study.
   J Infect. 2026 Aug 5:106823. doi: 10.1016/j.jinf.2026.106823.
   PubMed         Abstract available
   
   

   
   J Infect Dis

10. LIMA VD, Hussain SS, Yan J, Copp E, et al
    Incidence of Herpes Zoster Infection (Shingles) Among Adults Living With and Without HIV in British Columbia, Canada: A Population-Based Study.
    J Infect Dis. 2026 Mar 10:jiag118. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Pediatr

11. GROOM HC, Brooks N, Dandamudi P, Smith N, et al
    Meningococcal B Vaccination Patterns Across 10 Integrated Health Systems within Vaccine Safety Datalink, 2015-2023.
    J Pediatr. 2026 Aug 4:115274. doi: 10.1016/j.jpeds.2026.115274.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

12. BRETT TS, Tredennick A, Briga M, Coudeville L, et al
    Quantifying the impact of vaccination on pertussis dynamics in Sweden.
    PLoS Comput Biol. 2026;22:e1014538.
    PubMed         Abstract available
    
    

    
    PLoS One

13. ORDAK M
    Statistical misreasoning in online content about vaccines: Implications and recommendations for addressing disinformation.
    PLoS One. 2026;21:e0355341.
    PubMed         Abstract available
    
    
14. THARAKHET K, Prompetchara E, Khawsang C, Saithong S, et al
    Cross-serotype immunity elicited by a consensus dengue NS1 mRNA vaccine in mice.
    PLoS One. 2026;21:e0355389.
    PubMed         Abstract available
    
    

    
    Science

15. AGUIAR M
    Dengue vaccines need long-term surveillance.
    Science. 2026;393:572.
    PubMed        
    
    
16. COHEN J
    Weekly HIV pill moves closer but vaccine studies face new questions.
    Science. 2026;393:549-550.
    PubMed         Abstract available
    
    

    
    Vaccine

17. HAPOSAN JH, Thobari JA, Watts E, Pitzer VE, et al
    Cost-effectiveness and budget impact analyses of introducing typhoid conjugate vaccine into Indonesia's national immunisation program.
    Vaccine. 2026;90:129008.
    PubMed         Abstract available
    
    
18. NKODILA AN, Luvande RO, Nsana AB, Wembonyama SO, et al
    Systemic barriers to achieving yellow fever vaccination coverage targets among children aged 9-23 months in the Democratic Republic of the Congo.
    Vaccine. 2026;88:128995.
    PubMed         Abstract available
    
    
19. FREITAS CS, Lage DP, Pimenta BL, Falcao KOM, et al
    Recombinant vaccine plus anti-parasitic agent in an immunotherapeutic schedules induce partial regression of tegumentary leishmaniasis in a murine model.
    Vaccine. 2026;89:128990.
    PubMed         Abstract available
    
    
20. XU N, Wang L, Zhao C, Shen Y, et al
    Advances in clinical immunogenicity evaluation of influenza vaccines.
    Vaccine. 2026;89:128989.
    PubMed         Abstract available
    
    
21. SANDERS JG, Kroese F, Mehra S, Stok M, et al
    Switching the default: a formative evaluation of pre-booked appointments on COVID-19 vaccination uptake and effects on intended uptake.
    Vaccine. 2026;89:128967.
    PubMed         Abstract available
    
    
22. RUSSELL FA, Fisher MA, Leahy D, Harris J, et al
    Stability of Chlamydia pecorum MOMP at 37 degrees C: suitability for use in delayed-release vaccine implants in koalas (Phascolarctos cinereus).
    Vaccine. 2026;89:128991.
    PubMed         Abstract available
    
    
23. ZUNDONG Y, Xiaoxue L, Rodewald L, Fuzhen W, et al
    Entering into life-course immunization: Process, significance, and prospects of HPV vaccine inclusion into the national immunization program of China.
    Vaccine. 2026;89:129000.
    PubMed         Abstract available
    
    
24. AUGUSTO LV, de Araujo LP, Silva EN, Gutierres JM, et al
    Intersection of vaccination, health literacy, education, and communication in South America: A scientometric mapping.
    Vaccine. 2026;89:128986.
    PubMed         Abstract available
    
    
25. DJAWE K, Aigbogun E, Zoumanigui JS, Berete A, et al
    Strategies and lessons learned from a type 1 circulating vaccine-derived poliovirus (cVDPV) outbreak affecting adult population: Madagascar, 2020-2023.
    Vaccine. 2026;89:128987.
    PubMed         Abstract available
    
    
26. NEPALI R, King C, Leask J, Campbell E, et al
    A systematic review of knowledge, attitudes, and behaviour towards Japanese encephalitis vaccination.
    Vaccine. 2026;89:128999.
    PubMed         Abstract available
    
    
27. MAZIBUKO L, Hoor D, Nxumalo V, Nxumalo S, et al
    The association of individual, interpersonal and social support factors with willingness to vaccinate against COVID-19 in rural South Africa.
    Vaccine. 2026;89:128998.
    PubMed         Abstract available
    
    
28. DE WALS P
    The marketing authorization of vaccines is not an exact science: the 20-valent pneumococcal conjugate vaccine (PCV-20) is an example.
    Vaccine. 2026;90:128984.
    PubMed        
    
    
29. DOUCETTE EJ, Ricketson LJ, Murguia-Favela L, Wright N, et al
    Clinical features and outcomes of pediatric breakthrough invasive pneumococcal disease (IPD) in vaccinated children in Calgary, Alberta, Canada, 2003-2024.
    Vaccine. 2026;90:128977.
    PubMed         Abstract available
    
    
30. WEI W, Yang R, Wang Z, Feng S, et al
    A novel inactivated vaccine for cross-protection against Actinobacillus pleuropneumoniae in pigs.
    Vaccine. 2026;90:129010.
    PubMed         Abstract available
    
    
31. DAVIES HG, Rukundo G, Komugisha C, Kipyeko S, et al
    Baseline adverse birth outcomes in a prospective pregnancy cohort in Uganda: Evidence to inform maternal vaccine readiness.
    Vaccine. 2026;90:128952.
    PubMed         Abstract available
    
    

    
    Virology

32. SABIR AJ, Ross TM
    Advancing human metapneumovirus vaccine development through fusion protein stabilization.
    Virology. 2026;624:111043.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum